Investing in new technology: the PET experience
2003
Investing in new technology: the PET experience
Commentary
Evidence: low
Author Information
Author(s): Bradbury I, Facey K, Laking G, Sharp P
Primary Institution: NHS Quality Improvement Scotland
Conclusion
The assessment of PET imaging in cancer management suggests that while it may be clinically effective, more research is needed to demonstrate its value.
Supporting Evidence
- PET imaging has been shown to provide insights into tumor activity beyond just anatomical structure.
- Current research has focused more on the diagnostic accuracy of PET rather than its impact on long-term patient outcomes.
- HTA agencies have called for more prospective randomized studies to assess the utility of PET imaging.
Takeaway
This study talks about how new medical technologies like PET scans need to show they help patients before being widely used, and that more research is needed to prove their benefits.
Limitations
The study highlights the lack of long-term patient outcome data related to PET imaging and the challenges in conducting randomized controlled trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website